Skip to main content
Equibles

Andrew Funderburk

Head of Investor Relations

Monte Rosa Therapeutics, Inc. (GLUE)

Head of Investor Relations

Synlogic, Inc. (SYBX)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Andrew Funderburk

Andrew Funderburk is recorded as Head of Investor Relations at Monte Rosa Therapeutics, Inc. (GLUE) and Head of Investor Relations at Synlogic, Inc. (SYBX). Andrew Funderburk has spoken on 2 earnings calls across 1 company, most recently for Synlogic, Inc. on August 11, 2022.

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Synlogic, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Monte Rosa Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.